| Muscular Atrophy |
0 |
0.95 |
| Amyotrophic Lateral Sclerosis |
0 |
1 |
| Lipids Management |
0 |
0.99 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.98 |
| Cardiovascular Risk Management |
0 |
0.2 |
| Biomarker |
0 |
0.11 |
| Metabolism |
0 |
0.11 |
| Blood |
0 |
0.08 |
| LDL Cholesterol |
0 |
0.07 |
| Biologic Therapy |
0 |
0.06 |
| Lipoproteins |
0 |
0.06 |
| UK Site Content |
0 |
0.06 |
| Antioxidant |
0 |
0.03 |
| Brain |
0 |
0.03 |
| Death Certificates |
0 |
0.03 |
| Diversity |
0 |
0.03 |
| Gene Therapy |
0 |
0.03 |
| Genomic Medicine |
0 |
0.03 |
| Health Care Reform |
0 |
0.03 |
| Inpatient Care |
0 |
0.03 |
| Manipulation |
0 |
0.03 |
| Match |
0 |
0.03 |
| Michigan |
0 |
0.03 |
| Neurosurgery |
0 |
0.03 |
| Outpatient Clinic |
0 |
0.03 |
| Smoking |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |
| Statins |
0 |
0.03 |
| Tobacco Cessation |
0 |
0.03 |
| Triglycerides |
0 |
0.03 |